Charter Communications Enhances Offer for Liberty Broadband in Revised Takeover Deal
American Consumer Confidence Hits Record Low in May Economists Question Recovery Timeline
From Service to Skilled Trades The Untapped Pipeline Reshaping Americas Labor Market
MTAR Technologies Shares Retreat 3 After 24 Rally International Orders and Raised Guidance Underpin Outlook
Plus500 Reports 11 Revenue Growth in Latest Quarter Reaffirms FullYear Expectations
Global Stocks Rise Bond Yields Fall as USIran Talks Show Signs of Progress
PVL Q1 2023 Earnings Trust Reports Solid EPS Amid Quiet Quarter Stock Rises
GEG Q1 2026 Earnings Substantial EPS Miss Triggers Stock Decline
STOK Q1 2026 Earnings EPS Surprises to the Upside as Clinical Pipeline Advances
HYPD Q1 2026 Earnings Significant EPS Miss Sends Stock Down Over 7
VPG Q1 2026 Earnings EPS Surprise Beats Zero Estimate Stock Jumps
American Healthcare REIT Inc AHR Q1 2026 Earnings Strong EPS Beat Amidst Operational Improvements
SIBONE Inc SIBN Edges Lower Amid Consolidation Near Key Support Levels
CION Investment Corporation Notes CICC Edge Lower Amid Rate Sensitivity and Yield Comparisons
Chewy CHWY Holds Steady at Range Midpoint Amid Low Volatility
BioXcel Therapeutics BTAI Falls Further as Biotech Struggles to Hold Support
Ascent Solar Technologies ASTI Surges 12 as Momentum Builds Above Key Support
Coal India OFS Opens for Retail Investors Government to Sell Up to 2 Stake at 11 Discount
SP 500 Edges Higher as Healthcare and Technology Lead BroadBased Gains
Nvidia Stock in Focus June 2 Event May Shape AI Chip Market Outlook
TakeTwo Reaffirms GTA VI November Launch Despite Weaker Annual Bookings Forecast
Oil Prices Plunge Over 5 as Iran Nuclear Deal Hopes Intensify
Manufacturing Employment Data Underscore Uneven Impact of TrumpEra Tariffs Cato Institute Analysis Suggests
QYLDs High 12 Yield Could Attract Income Seekers but LongTerm Total Return Raises Questions
iBio Inc IBIO Q1 2026 Earnings EPS Miss on Higher RD Spend Stock Rises Despite No Revenue
Fractyl Health GUTS Dips Near Key Support After 662 Decline Biotech Volatility Continues